sirtex us media coverage valuation The media coverage along with the OTC listing will bring a whole new hoarde of US investors to the Sirtex story. In the US, biotechs usually are typically priced at PEG ratios of at least 2;1 ratios . PEG ratio is the Price earnings multiple/growth rate.Genentech sells at 63x P.E and growth rate is 30% PEG ratio= 63/30=2.1 The higher the PEG the more expensive the value of the share. Bioshares estimate of 100 million in revenue and net of 40 million for Sirtex this is 40/55million shares=73 cents in earnings if Sirtex was owned by big pharma right now as Huntley estimates that A LARGER SALESFORCE LIKE BIG PHARMA COULD KEEP UP WITH THE GROWing demand of Sir Sheres if they owned Sirtex. At $2.5 a share/73 cents= 3.2 PE with $140 % growth. PEG ratio for Sirtex = 3.2/140= .02. This means Genentech is 2.1/.02= 105x more expensive than Sirtex based on current growth rates and P.E ratios. It is easy to see why there are 4-5 major pharmas looking to acquire the Sir sphere technology from Sirtex and these companies need to gain competitive advantage over each other in the high margined oncology market.
- Forums
- ASX - By Stock
- bottomed
sirtex us media coverage valuation The media coverage along with...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SRX (ASX) to my watchlist
|
|||||
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.27M |
Open | High | Low | Value | Volume |
17.5¢ | 18.0¢ | 17.5¢ | $216.1K | 1.202M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 4652970 | 17.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 1579344 | 19 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 4652970 | 0.175 |
3 | 572000 | 0.170 |
3 | 107186 | 0.165 |
3 | 123900 | 0.160 |
3 | 947096 | 0.155 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 1520361 | 18 |
0.185 | 563260 | 6 |
0.190 | 87847 | 4 |
0.195 | 501787 | 3 |
0.200 | 531294 | 10 |
Last trade - 13.27pm 23/07/2024 (20 minute delay) ? |
Featured News
SRX (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & MD
Charles Armstrong
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online